SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Strategies & Market TrendsSpeculating in Takeover Targets


Previous 10 Next 10 
From: The Ox2/14/2017 8:32:21 AM
   of 7058
 
Hologic takes out Cynosure for $1.65B ($66/share)
Hologic (NASDAQ: HOLX) inks an agreement to acquire medical laser outfit Cynosure (NASDAQ: CYNO) for $66/share in cash ($1.65B).Hologic chief Steve McMillan says, "Acquiring Cynosure will accelerate our transformation into a higher-growth company by leveraging our core women's health expertise and OB/GYN channel leadership into an adjacent, cash-pay segment that is expanding at a low double-digit rate. We had identified medical aesthetics as an attractive and complementary growth opportunity through our strategic planning process, and are pleased to have agreed to acquire Cynosure, the best-in-class company in the space. Together, we can strengthen our shared focus on innovation, market-leading products with demonstrated clinical benefits, and strong customer relationships. "Hologic says the deal will be immediately accretive on a non-GAAP basis, adding $0.03 to 0.05 per share this year and $0.13 - 0.15 in 2018.The transaction should close no later than April.CYNO closed yesterday at $51.50. HOLX is down 2% premarket on light volume.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: The Ox who wrote (4373)2/14/2017 9:28:58 AM
From: richardred
   of 7058
 
This is about the quickest I can remember a competitor being taken out (BACK to Back). MY ANIK holding on this years SITT list has been heightened by me. This because of the successful DSCI takeout. I'm still speculating J & J and 3M would be a good fit (Wound care).

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (4346)2/16/2017 11:21:17 AM
From: richardred
   of 7058
 
Adding to some ANIK today. Although Mr. market was most likely looking for more. I didn't think earnings were that bad to warrant today's slide. Interga still in the buying mood. This before the close of MY DSCI.

Integra LifeSciences To Buy J & J Codman Neurosurgery Business For $1.045 Bln
(RTTNews.com) - Integra LifeSciences Holdings Corp. ( IART ) announced it has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of $1.045 billion in cash. Integra expects the transaction to be accretive to adjusted EPS by at least $0.22 in the first full year after closing and increasing thereafter, and to GAAP EPS by the end of the third year.

Integra LifeSciences expects the acquisition to also accelerate the path to achieving the company's targets of $2 billion in revenue and 30% adjusted EBITDA margin. Integra expects the Codman Neurosurgery revenue to experience some initial disruption in the first year of the combination, and to then grow 3% to 6% longer term.

Codman Neurosurgery is a part of Depuy Synthes Companies of Johnson & Johnson. It offers a portfolio of devices focused on advanced hydrocephalus, neuro-critical care and operative neurosurgery. The acquired products generated approximately $370 million in revenue during 2016 with an EBITDA margin of about 31%.

For comments and feedback: contact editorial@rttnews.com

rttnews.com

m.nasdaq.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (4367)2/16/2017 11:30:29 AM
From: richardred
   of 7058
 
Lots of consolidation going on in the lab space.



P.S.

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (4165)2/16/2017 1:53:04 PM
From: richardred
   of 7058
 
Sometimes I'm a glutton for punishment. Re-entered MCF today with a small buy.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (3729)2/16/2017 7:49:19 PM
From: robert b furman
   of 7058
 
COOL !!

It takes cajones to print our past.

I guess you did : "occasionally play options"

Privilege to know you Rick !!

Bob

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: robert b furman who wrote (4378)2/16/2017 7:56:58 PM
From: richardred
   of 7058
 
It's been frequently this year Bob. The same to you Bob

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (4290)2/19/2017 4:34:06 PM
From: richardred
   of 7058
 
RE- JVA is just a sip for someone. My stock sit on the back burner for now.

Farmer Brothers Completes $13.5 Million Acquisition of West Coast Coffee
West Coast Coffee Co. Facebook photo

Texas-based national coffee roaster, wholesaler and distributor Farmer Brothers has acquired Oregon-based roaster and distributor West Coast Coffee Company for $13.5 million, plus a potential $1 million dependent on future performance.

West Coast Coffee will operate as a subsidiary of Farmer Bros. within its direct store delivery (DSD) unit, the companies announced yesterday. West Coast Coffee currently has operations in Oregon, Washington, California and Nevada, with a focus on the convenience store, grocery and foodservice channels through direct and third-party distribution.

According to a Farmer Bros. announcement, WCC will maintain its offices and roasting plant in Hillsboro, near Portland, and the WCC management team — including General Manager James Beckman and Director of Operations Robert Vincent — will continue to run day-to-day operations.

“Their focus on quality products and customer service, combined with their coffee expertise, make the business a great strategic and cultural fit for Farmer Brothers,” Farmer Brothers CEO Mike Keown said in the announcement. “James Beckman and Robert Vinson should be proud of their work building the West Coast Coffee brands across retail and foodservice channels.”

dailycoffeenews.com

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: richardred who wrote (4298)2/22/2017 10:30:47 AM
From: richardred
   of 7058
 
Selling All HAR today. I'm not waiting for the merger to be completed by Samsung. Investing some proceeds into MNTX today. This on it's recent dip.

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (4357)2/23/2017 12:54:37 PM
From: richardred
   of 7058
 
RE-CTG Impressed with the new board addition and the new compensation package. RE- If the stock price doesn't go up. The board gets nothing. Just guessing down the road. Once changes in the health care system are finalized and implemented. This will lead to less uncertainty and improved business for CTG in it's health care area. There's Lots of stock to purchase under the current BB program. RE:CC The board also considers the stock undervalued at current prices.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10